| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | ATP6V1C1 MYH8 BRIP1 MCM8 ABCA13 ATAD5 DNAH14 HELB DHX9 ABCC8 SHOC1 ASCC3 HSPA1L HSPA6 HSPA9 PMS2 KIF27 MYH7B DDX52 ABCC11 MSH4 DNAH1 MYO1F MACF1 | 7.25e-09 | 614 | 194 | 24 | GO:0140657 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | MYH8 BRIP1 MCM8 ABCA13 ATAD5 HELB DHX9 ABCC8 SHOC1 ASCC3 HSPA1L HSPA6 HSPA9 PMS2 KIF27 DDX52 ABCC11 MACF1 | 3.29e-07 | 441 | 194 | 18 | GO:0016887 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYH8 SPTBN1 SPTBN2 EPS8L1 NEB SYNE2 MICAL3 USH2A AGTPBP1 RHCG KIF27 MYH7B ANXA2 ANXA2P2 TPGS1 FHOD3 SHANK3 RGS14 FEZ1 XIRP2 TTLL2 MYLIP MYO1F MACF1 RP1 SAMD14 TTLL13 | 8.46e-06 | 1099 | 194 | 27 | GO:0008092 |
| GeneOntologyMolecularFunction | actin filament binding | MYH8 SPTBN1 SPTBN2 EPS8L1 NEB MYH7B FHOD3 XIRP2 MYO1F MACF1 SAMD14 | 1.43e-05 | 227 | 194 | 11 | GO:0051015 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | MYH8 BRIP1 MCM8 ABCA13 ATAD5 HELB DHX9 ABCC8 SHOC1 ASCC3 HSPA1L HSPA6 HSPA9 PMS2 KIF27 DDX52 ABCC11 ARHGAP35 RGS14 RRAGA MACF1 | 2.25e-05 | 775 | 194 | 21 | GO:0017111 |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 3.43e-05 | 127 | 194 | 8 | GO:0008094 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | MYH8 BRIP1 MCM8 ABCA13 ATAD5 HELB DHX9 ABCC8 SHOC1 ASCC3 HSPA1L HSPA6 HSPA9 PMS2 KIF27 DDX52 ABCC11 ARHGAP35 RGS14 RRAGA MACF1 | 7.07e-05 | 839 | 194 | 21 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | MYH8 BRIP1 MCM8 ABCA13 ATAD5 HELB DHX9 ABCC8 SHOC1 ASCC3 HSPA1L HSPA6 HSPA9 PMS2 KIF27 DDX52 ABCC11 ARHGAP35 RGS14 RRAGA MACF1 | 7.19e-05 | 840 | 194 | 21 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | MYH8 BRIP1 MCM8 ABCA13 ATAD5 HELB DHX9 ABCC8 SHOC1 ASCC3 HSPA1L HSPA6 HSPA9 PMS2 KIF27 DDX52 ABCC11 ARHGAP35 RGS14 RRAGA MACF1 | 7.19e-05 | 840 | 194 | 21 | GO:0016818 |
| GeneOntologyMolecularFunction | bone sialoprotein binding | 9.39e-05 | 2 | 194 | 2 | GO:0044730 | |
| GeneOntologyMolecularFunction | protein-glutamic acid ligase activity | 1.03e-04 | 10 | 194 | 3 | GO:0070739 | |
| GeneOntologyMolecularFunction | tubulin-glutamic acid ligase activity | 1.03e-04 | 10 | 194 | 3 | GO:0070740 | |
| GeneOntologyMolecularFunction | actin binding | MYH8 SPTBN1 SPTBN2 EPS8L1 NEB SYNE2 MICAL3 MYH7B FHOD3 SHANK3 XIRP2 MYO1F MACF1 SAMD14 | 2.58e-04 | 479 | 194 | 14 | GO:0003779 |
| GeneOntologyMolecularFunction | DNA helicase activity | 3.40e-04 | 62 | 194 | 5 | GO:0003678 | |
| GeneOntologyMolecularFunction | lipase inhibitor activity | 6.62e-04 | 18 | 194 | 3 | GO:0055102 | |
| GeneOntologyMolecularFunction | phospholipase A2 inhibitor activity | 9.21e-04 | 5 | 194 | 2 | GO:0019834 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.04e-03 | 118 | 194 | 6 | GO:0003774 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 1.09e-03 | 262 | 194 | 9 | GO:0140097 | |
| GeneOntologyMolecularFunction | deubiquitinase activity | 1.35e-03 | 124 | 194 | 6 | GO:0101005 | |
| GeneOntologyMolecularFunction | histone H2A deubiquitinase activity | 1.37e-03 | 6 | 194 | 2 | GO:0140950 | |
| GeneOntologyMolecularFunction | acid-amino acid ligase activity | 1.39e-03 | 23 | 194 | 3 | GO:0016881 | |
| GeneOntologyMolecularFunction | single-stranded DNA helicase activity | 1.39e-03 | 23 | 194 | 3 | GO:0017116 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | TRIT1 BRIP1 MCM8 ATAD5 NT5C3A HELB DHX9 THG1L ASCC3 PMS2 DDX52 TUT7 MSH4 LIG3 EXOSC7 | 1.64e-03 | 645 | 194 | 15 | GO:0140640 |
| GeneOntologyMolecularFunction | cadherin binding | SPTBN1 SPTBN2 EXOC3 EPS8L1 ANXA2 DOCK9 PKP4 CDH19 MACF1 CDH2 | 1.83e-03 | 339 | 194 | 10 | GO:0045296 |
| GeneOntologyMolecularFunction | MutSalpha complex binding | 1.91e-03 | 7 | 194 | 2 | GO:0032407 | |
| GeneOntologyMolecularFunction | lipase binding | 1.91e-03 | 7 | 194 | 2 | GO:0035473 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein peptidase activity | 2.23e-03 | 137 | 194 | 6 | GO:0019783 | |
| GeneOntologyBiologicalProcess | cilium assembly | TTC39C KIAA0586 DRC1 FSIP2 CDKL5 SYNE2 PKHD1 WDR35 TBC1D15 KIF27 CEP162 TPGS1 ARHGAP35 DNAH1 CELSR3 RP1 CCDC63 | 1.18e-06 | 444 | 195 | 17 | GO:0060271 |
| GeneOntologyBiologicalProcess | low-density lipoprotein particle clearance | 2.26e-06 | 41 | 195 | 6 | GO:0034383 | |
| GeneOntologyBiologicalProcess | cilium organization | TTC39C KIAA0586 DRC1 FSIP2 CDKL5 SYNE2 PKHD1 WDR35 TBC1D15 KIF27 CEP162 TPGS1 ARHGAP35 DNAH1 CELSR3 RP1 CCDC63 | 3.02e-06 | 476 | 195 | 17 | GO:0044782 |
| GeneOntologyBiologicalProcess | regulation of low-density lipoprotein particle receptor catabolic process | 2.83e-05 | 7 | 195 | 3 | GO:0032803 | |
| GeneOntologyBiologicalProcess | low-density lipoprotein particle receptor catabolic process | 2.83e-05 | 7 | 195 | 3 | GO:0032802 | |
| GeneOntologyBiologicalProcess | low-density lipoprotein receptor particle metabolic process | 2.83e-05 | 7 | 195 | 3 | GO:0032799 | |
| GeneOntologyBiologicalProcess | cell projection assembly | TTC39C KIAA0586 DRC1 EPS8L1 FSIP2 CDKL5 SYNE2 PKHD1 WDR35 TBC1D15 KIF27 CEP162 TPGS1 ARHGAP35 CYFIP2 DNAH1 CELSR3 RP1 CCDC63 | 2.87e-05 | 685 | 195 | 19 | GO:0030031 |
| GeneOntologyBiologicalProcess | plasma lipoprotein particle clearance | 2.87e-05 | 63 | 195 | 6 | GO:0034381 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | TTC39C KIAA0586 DRC1 EPS8L1 FSIP2 CDKL5 SYNE2 PKHD1 WDR35 TBC1D15 KIF27 CEP162 TPGS1 ARHGAP35 DNAH1 CELSR3 RP1 CCDC63 | 7.06e-05 | 670 | 195 | 18 | GO:0120031 |
| GeneOntologyBiologicalProcess | regulation of low-density lipoprotein particle clearance | 7.10e-05 | 24 | 195 | 4 | GO:0010988 | |
| GeneOntologyBiologicalProcess | regulation of anatomical structure size | SPTBN1 SPTBN2 FSTL4 NEB CDKL5 SCNN1B WDR35 FGA SLC12A6 HTR2B FHOD3 ARHGAP35 CIT SHANK3 CYFIP2 SLIT1 MACF1 | 8.48e-05 | 618 | 195 | 17 | GO:0090066 |
| GeneOntologyBiologicalProcess | positive regulation of low-density lipoprotein particle receptor binding | 8.89e-05 | 2 | 195 | 2 | GO:1905597 | |
| GeneOntologyBiologicalProcess | cell junction organization | PRTN3 CACNA2D2 SPTBN2 PCDH17 CDKL5 ABCC8 PKHD1 FGFR2 SORBS2 LAMTOR2 HTR4 C1QL3 PKP4 ADGRL1 CDH19 SHANK3 CYFIP2 XIRP2 SLIT1 MACF1 SRGAP2B CDH2 | 1.42e-04 | 974 | 195 | 22 | GO:0034330 |
| GeneOntologyBiologicalProcess | peptidyl-glutamic acid modification | 1.53e-04 | 29 | 195 | 4 | GO:0018200 | |
| GeneOntologyBiologicalProcess | organelle assembly | TTC39C SPTBN2 KIAA0586 DRC1 NEB FSIP2 CDKL5 SYNE2 PKHD1 WDR35 TBC1D15 KIF27 CEP162 C1QL3 TPGS1 FHOD3 ARHGAP35 SHANK3 DNAH1 CELSR3 FEZ1 RP1 ATM CCDC63 | 1.96e-04 | 1138 | 195 | 24 | GO:0070925 |
| GeneOntologyBiologicalProcess | regulation of cellular component size | SPTBN1 SPTBN2 FSTL4 NEB CDKL5 SLC12A6 FHOD3 ARHGAP35 CIT SHANK3 CYFIP2 SLIT1 MACF1 | 2.19e-04 | 426 | 195 | 13 | GO:0032535 |
| GeneOntologyBiologicalProcess | protein polyglutamylation | 2.22e-04 | 13 | 195 | 3 | GO:0018095 | |
| GeneOntologyBiologicalProcess | postsynapse assembly | 2.55e-04 | 93 | 195 | 6 | GO:0099068 | |
| GeneOntologyBiologicalProcess | microtubule-based movement | DRC1 FYCO1 DNAH14 FSIP2 SYNE2 WDR35 AGTPBP1 KIF27 TPGS1 APOB DNAH1 FEZ1 CCDC63 INVS | 2.63e-04 | 493 | 195 | 14 | GO:0007018 |
| GeneOntologyBiologicalProcess | positive regulation of receptor-mediated endocytosis involved in cholesterol transport | 2.65e-04 | 3 | 195 | 2 | GO:1905602 | |
| GeneOntologyBiologicalProcess | negative regulation of low-density lipoprotein particle receptor catabolic process | 2.65e-04 | 3 | 195 | 2 | GO:0032804 | |
| GeneOntologyBiologicalProcess | regulation of receptor catabolic process | 2.80e-04 | 14 | 195 | 3 | GO:2000644 | |
| GeneOntologyCellularComponent | actin cytoskeleton | MYH8 SPTBN1 SPTBN2 NEB DHX9 SORBS2 MYH7B ANXA2 ANXA2P2 FHOD3 ARHGAP35 CIT XIRP2 MYO1F MACF1 SAMD14 CDH2 | 3.67e-05 | 576 | 198 | 17 | GO:0015629 |
| GeneOntologyCellularComponent | cilium | IMPG1 KIAA0586 DRC1 DNAH14 FSIP2 CDKL5 PKHD1 WDR35 USH2A KIF27 CEP162 PCDHB15 TPGS1 ARHGAP35 SHANK3 DNAH1 DUSP21 TTLL2 RP1 TTLL13 CCDC63 INVS | 4.50e-05 | 898 | 198 | 22 | GO:0005929 |
| GeneOntologyCellularComponent | cell cortex | SPTBN1 SPTBN2 EXOC3 TRIP10 FGA MICAL3 FGFR2 ANXA2 ANXA2P2 MYO1F MACF1 CDH2 | 2.30e-04 | 371 | 198 | 12 | GO:0005938 |
| GeneOntologyCellularComponent | AnxA2-p11 complex | 2.66e-04 | 3 | 198 | 2 | GO:1990665 | |
| GeneOntologyCellularComponent | PCSK9-AnxA2 complex | 2.66e-04 | 3 | 198 | 2 | GO:1990667 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | PRTN3 IMPG1 COL6A5 FREM1 FGA NID1 FGFR2 USH2A IMPG2 ANXA2 ANXA2P2 ORM1 ORM2 CDH2 | 5.52e-04 | 530 | 198 | 14 | GO:0062023 |
| GeneOntologyCellularComponent | microtubule | TRIP10 DNAH14 BOD1 KIF27 CEP162 TPGS1 DNAH1 RGS14 DUSP21 FEZ1 MACF1 RP1 TTLL13 INVS | 5.84e-04 | 533 | 198 | 14 | GO:0005874 |
| GeneOntologyCellularComponent | apical plasma membrane | SPTBN2 SLC5A7 PKHD1 SCNN1B USH2A RHCG SLC12A6 NAALADL1 SORBS2 ABCC11 MAL2 SLC26A11 CDH2 | 7.89e-04 | 487 | 198 | 13 | GO:0016324 |
| GeneOntologyCellularComponent | supramolecular fiber | MYH8 SPTBN1 NEB TRIP10 DNAH14 BOD1 SYNE2 SORBS2 KIF27 MYH7B CEP162 TPGS1 FHOD3 DNAH1 RGS14 DUSP21 FEZ1 XIRP2 MYO1F MACF1 RP1 TTLL13 INVS | 8.18e-04 | 1179 | 198 | 23 | GO:0099512 |
| GeneOntologyCellularComponent | photoreceptor inner segment | 8.74e-04 | 78 | 198 | 5 | GO:0001917 | |
| GeneOntologyCellularComponent | supramolecular polymer | MYH8 SPTBN1 NEB TRIP10 DNAH14 BOD1 SYNE2 SORBS2 KIF27 MYH7B CEP162 TPGS1 FHOD3 DNAH1 RGS14 DUSP21 FEZ1 XIRP2 MYO1F MACF1 RP1 TTLL13 INVS | 8.95e-04 | 1187 | 198 | 23 | GO:0099081 |
| GeneOntologyCellularComponent | mitochondrial outer membrane translocase complex | 1.13e-03 | 22 | 198 | 3 | GO:0005742 | |
| GeneOntologyCellularComponent | outer mitochondrial membrane protein complex | 1.29e-03 | 23 | 198 | 3 | GO:0098799 | |
| GeneOntologyCellularComponent | interphotoreceptor matrix | 1.31e-03 | 6 | 198 | 2 | GO:0033165 | |
| Domain | P-loop_NTPase | TRIT1 MYH8 BRIP1 MCM8 ABCA13 ATAD5 DNAH14 HELB DHX9 DAP3 SAMD9L ABCC8 ASCC3 KIF27 MYH7B DDX52 ABCC11 MSH4 ARHGAP35 DNAH1 RRAGA MYO1F | 6.32e-05 | 848 | 192 | 22 | IPR027417 |
| Domain | SEA | 6.85e-05 | 22 | 192 | 4 | PF01390 | |
| Domain | Spectrin | 8.22e-05 | 23 | 192 | 4 | PF00435 | |
| Domain | ACTININ_2 | 8.22e-05 | 23 | 192 | 4 | PS00020 | |
| Domain | ACTININ_1 | 8.22e-05 | 23 | 192 | 4 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 8.22e-05 | 23 | 192 | 4 | IPR001589 | |
| Domain | SEA | 8.22e-05 | 23 | 192 | 4 | PS50024 | |
| Domain | SEA_dom | 8.22e-05 | 23 | 192 | 4 | IPR000082 | |
| Domain | PH_dom-spectrin-type | 8.58e-05 | 9 | 192 | 3 | IPR001605 | |
| Domain | A1A_glycop | 1.05e-04 | 2 | 192 | 2 | IPR001500 | |
| Domain | Spectrin_repeat | 2.10e-04 | 29 | 192 | 4 | IPR002017 | |
| Domain | Cadherin | 2.19e-04 | 118 | 192 | 7 | IPR002126 | |
| Domain | - | 2.20e-04 | 12 | 192 | 3 | 2.60.34.10 | |
| Domain | HSP70_peptide-bd | 2.20e-04 | 12 | 192 | 3 | IPR029047 | |
| Domain | - | TRIT1 BRIP1 MCM8 ABCA13 ATAD5 DNAH14 HELB DHX9 DAP3 SAMD9L ABCC8 ASCC3 DDX52 ABCC11 MSH4 ARHGAP35 DNAH1 RRAGA MYO1F | 2.58e-04 | 746 | 192 | 19 | 3.40.50.300 |
| Domain | - | 2.84e-04 | 13 | 192 | 3 | 1.20.1270.10 | |
| Domain | Heat_shock_70_CS | 2.84e-04 | 13 | 192 | 3 | IPR018181 | |
| Domain | HSP70_C | 2.84e-04 | 13 | 192 | 3 | IPR029048 | |
| Domain | SPEC | 3.11e-04 | 32 | 192 | 4 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 3.11e-04 | 32 | 192 | 4 | IPR018159 | |
| Domain | SEA | 3.58e-04 | 14 | 192 | 3 | SM00200 | |
| Domain | HSP70 | 5.43e-04 | 16 | 192 | 3 | PF00012 | |
| Domain | CH | 5.46e-04 | 65 | 192 | 5 | SM00033 | |
| Domain | Spectrin_bsu | 6.22e-04 | 4 | 192 | 2 | IPR016343 | |
| Domain | HSP70_2 | 6.54e-04 | 17 | 192 | 3 | PS00329 | |
| Domain | HSP70_1 | 6.54e-04 | 17 | 192 | 3 | PS00297 | |
| Domain | HSP70_3 | 6.54e-04 | 17 | 192 | 3 | PS01036 | |
| Domain | CH | 7.68e-04 | 70 | 192 | 5 | PF00307 | |
| Domain | Hsp_70_fam | 7.79e-04 | 18 | 192 | 3 | IPR013126 | |
| Domain | - | 8.19e-04 | 71 | 192 | 5 | 1.10.418.10 | |
| Domain | Cadherin_CS | 9.20e-04 | 109 | 192 | 6 | IPR020894 | |
| Domain | CH | 9.30e-04 | 73 | 192 | 5 | PS50021 | |
| Domain | CH-domain | 1.05e-03 | 75 | 192 | 5 | IPR001715 | |
| Domain | CADHERIN_1 | 1.11e-03 | 113 | 192 | 6 | PS00232 | |
| Domain | Cadherin | 1.11e-03 | 113 | 192 | 6 | PF00028 | |
| Domain | CADHERIN_2 | 1.16e-03 | 114 | 192 | 6 | PS50268 | |
| Domain | - | 1.16e-03 | 114 | 192 | 6 | 2.60.40.60 | |
| Domain | CA | 1.22e-03 | 115 | 192 | 6 | SM00112 | |
| Domain | Cadherin-like | 1.27e-03 | 116 | 192 | 6 | IPR015919 | |
| Domain | FCH | 1.43e-03 | 22 | 192 | 3 | PF00611 | |
| Domain | FCH | 1.43e-03 | 22 | 192 | 3 | SM00055 | |
| Domain | FCH_dom | 1.63e-03 | 23 | 192 | 3 | IPR001060 | |
| Pubmed | ATP6V1C1 SPTBN1 SPTBN2 SUCLA2 LUZP1 DHX9 CDKL5 TOMM70 SEC16A FGA MICAL3 IMMT HSPA9 AGTPBP1 SLC12A6 SORBS2 ANXA2 ANXA2P2 PKP4 ADGRL1 TPGS1 ARHGAP35 CIT SHANK3 CYFIP2 MAL2 PPP2R2C MACF1 CDH2 | 3.18e-09 | 1431 | 198 | 29 | 37142655 | |
| Pubmed | ABCA13 NEB HELB DHX9 GREB1L NID1 HSPA1L IMMT HSPA6 HSPA9 AGTPBP1 CPNE9 APOB ARHGAP35 MINDY2 CELSR3 | 4.86e-08 | 513 | 198 | 16 | 25798074 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | SPTBN1 SPTBN2 LUZP1 SORBS2 ANXA2 ANXA2P2 PKP4 CIT SHANK3 CYFIP2 MACF1 | 7.19e-07 | 281 | 198 | 11 | 28706196 |
| Pubmed | Accumulation of glycosphingolipids in Niemann-Pick C disease disrupts endosomal transport. | 7.24e-07 | 4 | 198 | 3 | 15078881 | |
| Pubmed | 7.24e-07 | 4 | 198 | 3 | 10036317 | ||
| Pubmed | GALNT2 FYCO1 LUZP1 MGAT2 FAF2 CHPF2 TAF2 ASCC3 IMMT TBC1D15 PPP2R2C | 8.25e-07 | 285 | 198 | 11 | 32838362 | |
| Pubmed | SPTBN1 SPTBN2 ANXA2 ANXA2P2 PKP4 RAB11FIP2 APOB SHANK3 RGS14 CDH2 | 1.01e-06 | 233 | 198 | 10 | 29518331 | |
| Pubmed | EXOC3 SEC16A MICAL3 SLC12A6 PKP4 RAB11FIP2 ADGRL1 TPGS1 FAM171B CYFIP2 MACF1 PLEKHA2 CDH2 | 1.02e-06 | 421 | 198 | 13 | 36976175 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | SPTBN1 SPTBN2 EXOC3 NEB FGA NID1 MICAL3 ASCC3 HTR2B DOCK9 XIRP2 RP1 ATM USP39 | 1.15e-06 | 497 | 198 | 14 | 36774506 |
| Pubmed | PDE3B ZNF148 MLEC ATAD5 SPTBN1 SPTBN2 EXOC3 SUCLA2 DMXL1 DHX9 DAP3 FAF2 SYNE2 BUB1B ASCC3 HSPA1L IMMT HSPA6 HSPA9 AGTPBP1 TBC1D15 PKP4 SNW1 MACF1 ATM | 1.38e-06 | 1487 | 198 | 25 | 33957083 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | RNF130 PDE3B GALNT2 MCM8 CACNA2D2 SUCLA2 DNAH14 ABCC8 MICAL3 MME CRAMP1 USP53 SLC12A6 STAP2 ADGRL1 TPGS1 ARHGAP35 DNAH1 MIPOL1 PPP2R2C ZNF827 SCARB1 MACF1 PLEKHA2 INVS | 1.41e-06 | 1489 | 198 | 25 | 28611215 |
| Pubmed | MYH8 SPTBN1 SPTBN2 NEB LUZP1 DAP3 SYNE2 PKHD1 TASOR HSPA1L IMMT HSPA6 HSPA9 SLC12A6 MYH7B ANXA2 DDX52 APOB MINDY2 CYFIP2 MIPOL1 RGS14 MACF1 ATM | 2.72e-06 | 1442 | 198 | 24 | 35575683 | |
| Pubmed | 2.93e-06 | 153 | 198 | 8 | 10718198 | ||
| Pubmed | Feto-maternal cholesterol transport regulated by β-Klotho-FGF15 axis is essential for fetal growth. | 3.69e-06 | 19 | 198 | 4 | 37541847 | |
| Pubmed | PDE3B GALNT2 MLEC FYCO1 BIRC6 LUZP1 DHX9 TOMM70 MGAT2 CHPF2 ASCC3 IMMT NPC1 ANXA2 DDX52 DOCK9 ANO10 CIT COG8 CYFIP2 PSD4 | 3.70e-06 | 1168 | 198 | 21 | 19946888 | |
| Pubmed | TOMM70 FAF2 SEC16A CHPF2 MICAL3 AGTPBP1 SORBS2 DOCK9 ADGRL1 FEM1B SLIT1 MACF1 | 4.29e-06 | 407 | 198 | 12 | 12693553 | |
| Pubmed | 4.60e-06 | 20 | 198 | 4 | 21689717 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | SPTBN1 SPTBN2 EXOC3 EPS8L1 LUZP1 CDKL5 ANXA2 DOCK9 PKP4 FAM171B SCYL2 SCARB1 MACF1 PLEKHA2 | 5.06e-06 | 565 | 198 | 14 | 25468996 |
| Pubmed | ZNF148 BIRC6 LUZP1 GREB1L BUB1B SEC16A ASCC3 TASOR HSPA6 TBC1D15 TPGS1 PLEKHA2 | 5.62e-06 | 418 | 198 | 12 | 34709266 | |
| Pubmed | 6.11e-06 | 169 | 198 | 8 | 31462741 | ||
| Pubmed | Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes? | 6.38e-06 | 170 | 198 | 8 | 23314748 | |
| Pubmed | The G protein-coupled receptor CL1 interacts directly with proteins of the Shank family. | 9.97e-06 | 8 | 198 | 3 | 10958799 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | RNF130 FAM234A ZNF148 NT5C3A GOLM1 TOMM70 FAF2 SEC16A FGA HSPA1L HSPA6 ABHD16A HSPA9 SLC12A6 APOB SCARB1 MACF1 ATM PCDH9 | 1.16e-05 | 1061 | 198 | 19 | 33845483 |
| Pubmed | 1.43e-05 | 54 | 198 | 5 | 22266860 | ||
| Pubmed | ZRANB1 Is an EZH2 Deubiquitinase and a Potential Therapeutic Target in Breast Cancer. | 1.49e-05 | 9 | 198 | 3 | 29669287 | |
| Pubmed | 1.72e-05 | 56 | 198 | 5 | 20706999 | ||
| Pubmed | ZNF148 SPTBN2 LUZP1 BUB1B SEC16A TAF2 ASCC3 HSPA6 TBC1D15 ANXA2 ARHGAP35 SCYL2 SNW1 | 1.78e-05 | 549 | 198 | 13 | 38280479 | |
| Pubmed | 1.86e-05 | 197 | 198 | 8 | 36604605 | ||
| Pubmed | 1.87e-05 | 28 | 198 | 4 | 38492217 | ||
| Pubmed | 2.22e-05 | 59 | 198 | 5 | 32382008 | ||
| Pubmed | 2.23e-05 | 331 | 198 | 10 | 29199018 | ||
| Pubmed | 2.27e-05 | 147 | 198 | 7 | 29576527 | ||
| Pubmed | FAM234A KIAA0586 DNAH14 FREM1 DMXL1 GREB1L FGA NID1 MICAL3 FGFR2 ASCC3 AGTPBP1 SORBS2 TUT7 ANO10 SCYL2 ZNF100 FEZ1 SAMD14 CDH2 | 2.27e-05 | 1215 | 198 | 20 | 15146197 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | ATP6V1C1 PRTN3 SPTBN1 EPS8L1 NEB SUCLA2 TRIP10 PKHD1 FGA NID1 MME NPC1 RHCG ANXA2 ABCC11 CYFIP2 MAL2 SLC26A11 | 2.30e-05 | 1016 | 198 | 18 | 19056867 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | PDE3B SPTBN2 SLC5A7 BIRC6 DNAH14 PCDH17 DHX9 SAMD9L PKHD1 USP22 MIPOL1 LIG3 ATM USP39 SLC26A11 | 2.33e-05 | 736 | 198 | 15 | 29676528 |
| Pubmed | PDE3B GALNT2 MCM8 EXOC3 FAM111B TOMM70 BUB1B CHPF2 MICAL3 TASOR PKP4 TUT7 LIG3 RIOK2 | 2.41e-05 | 650 | 198 | 14 | 38777146 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 2.75e-05 | 208 | 198 | 8 | 33230847 | |
| Pubmed | 2.81e-05 | 152 | 198 | 7 | 34299191 | ||
| Pubmed | 2.85e-05 | 209 | 198 | 8 | 36779422 | ||
| Pubmed | SPTBN2 KIAA0586 ZNF623 BIRC6 MYSM1 SAMD9L WDR35 MICAL3 TASOR ARHGAP35 SHANK3 MACF1 | 2.88e-05 | 493 | 198 | 12 | 15368895 | |
| Pubmed | Variants in LRRC7 lead to intellectual disability, autism, aggression and abnormal eating behaviors. | 2.90e-05 | 11 | 198 | 3 | 39256359 | |
| Pubmed | PRTN3 SPTBN2 LUZP1 HSPA1L AGTPBP1 TUT7 FHOD3 APOB DNAH1 SCYL2 MACF1 EXOSC7 | 3.06e-05 | 496 | 198 | 12 | 31343991 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | FAM234A PDE3B GALNT2 NT5C3A GOLM1 TOMM70 MGAT2 FAF2 CHPF2 ASCC3 IMMT HSPA6 NPC1 TBC1D15 DDX52 TUT7 COG8 | 3.10e-05 | 942 | 198 | 17 | 31073040 |
| Pubmed | MYH8 SPTBN1 NEB BIRC6 TOMM70 SYNE2 HSPA9 AGTPBP1 SLC12A6 DOCK9 XIRP2 MACF1 | 3.12e-05 | 497 | 198 | 12 | 23414517 | |
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 24389491 | ||
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 15253437 | ||
| Pubmed | Selective binding of coumarin enantiomers to human alpha1-acid glycoprotein genetic variants. | 3.22e-05 | 2 | 198 | 2 | 16290938 | |
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 15157739 | ||
| Pubmed | Orosomucoid-1 Arises as a Shared Altered Protein in Two Models of Multiple Sclerosis. | 3.22e-05 | 2 | 198 | 2 | 37949310 | |
| Pubmed | Comparison of alpha-1-acid glycoprotein isoforms from healthy and cancer patients by capillary IEF. | 3.22e-05 | 2 | 198 | 2 | 17987628 | |
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 19536308 | ||
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 34210751 | ||
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 37640741 | ||
| Pubmed | Annexin A2 modulates radiation-sensitive transcriptional programming and cell fate. | 3.22e-05 | 2 | 198 | 2 | 23148505 | |
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 33846468 | ||
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 25085631 | ||
| Pubmed | Transcriptome Analysis Uncovers a Growth-Promoting Activity of Orosomucoid-1 on Hepatocytes. | 3.22e-05 | 2 | 198 | 2 | 28927749 | |
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 38290972 | ||
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 22415874 | ||
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 4711474 | ||
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 3013423 | ||
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 35064931 | ||
| Pubmed | Structure and expression of the genes coding for human alpha 1-acid glycoprotein. | 3.22e-05 | 2 | 198 | 2 | 2822385 | |
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 20442402 | ||
| Pubmed | Complex Roles of Annexin A2 in Host Blood-Brain Barrier Invasion by Cryptococcus neoformans. | 3.22e-05 | 2 | 198 | 2 | 28130864 | |
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 33608777 | ||
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 25264156 | ||
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 15925089 | ||
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 17549680 | ||
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 2354997 | ||
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 36109576 | ||
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 39384746 | ||
| Pubmed | Structural heterogeneity of glycoform of alpha-1 Acid glycoprotein in alcoholic cirrhosis patients. | 3.22e-05 | 2 | 198 | 2 | 25408356 | |
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 20826156 | ||
| Pubmed | Nucleotide sequence of the mouse alpha 1-acid glycoprotein gene 1. | 3.22e-05 | 2 | 198 | 2 | 3676251 | |
| Pubmed | Structure and characterisation of a duplicated human alpha 1 acid glycoprotein gene. | 3.22e-05 | 2 | 198 | 2 | 2970990 | |
| Pubmed | Prohibitin/annexin 2 interaction regulates fatty acid transport in adipose tissue. | 3.22e-05 | 2 | 198 | 2 | 27468426 | |
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 4603214 | ||
| Pubmed | Homocysteine inhibits neoangiogenesis in mice through blockade of annexin A2-dependent fibrinolysis. | 3.22e-05 | 2 | 198 | 2 | 19841537 | |
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 27389701 | ||
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 37853937 | ||
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 17360942 | ||
| Pubmed | Annexin A2 regulates phagocytosis of photoreceptor outer segments in the mouse retina. | 3.22e-05 | 2 | 198 | 2 | 19587120 | |
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 19022301 | ||
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 22951594 | ||
| Pubmed | A mouse gene family associated with a major submaxillary-gland glycoprotein. | 3.22e-05 | 2 | 198 | 2 | 3977853 | |
| Pubmed | Structure and expression of mouse alpha 1-acid glycoprotein gene-3 (AGP-3). | 3.22e-05 | 2 | 198 | 2 | 1605854 | |
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 38253182 | ||
| Pubmed | Caspase-3/7-mediated Cleavage of β2-spectrin is Required for Acetaminophen-induced Liver Damage. | 3.22e-05 | 2 | 198 | 2 | 26884715 | |
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 37975905 | ||
| Pubmed | Annexin A2 is a novel cellular redox regulatory protein involved in tumorigenesis. | 3.22e-05 | 2 | 198 | 2 | 22185818 | |
| Pubmed | Analysis of the five glycosylation sites of human alpha 1-acid glycoprotein. | 3.22e-05 | 2 | 198 | 2 | 1567356 | |
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 28554261 | ||
| Pubmed | A competitive hexapeptide inhibitor of annexin A2 prevents hypoxia-induced angiogenic events. | 3.22e-05 | 2 | 198 | 2 | 21486955 | |
| Pubmed | Lipid raft endocytosis and exosomal transport facilitate extracellular trafficking of annexin A2. | 3.22e-05 | 2 | 198 | 2 | 21737841 | |
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 19580511 | ||
| Pubmed | Evidence for the existence of multiple alpha 1-acid glycoprotein genes in the mouse. | 3.22e-05 | 2 | 198 | 2 | 3003086 | |
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 1371400 | ||
| Pubmed | Proteoglycan IMPG2 Shapes the Interphotoreceptor Matrix and Modulates Vision. | 3.22e-05 | 2 | 198 | 2 | 32265257 | |
| Pubmed | Structure of human alpha1-acid glycoprotein and its high-affinity binding site. | 3.22e-05 | 2 | 198 | 2 | 12480518 | |
| Interaction | SYNPO interactions | SPTBN1 SPTBN2 LUZP1 SEC16A NPC1 SORBS2 ANXA2 CEP162 CIT SHANK3 RGS14 | 2.80e-06 | 192 | 195 | 11 | int:SYNPO |
| Interaction | MLH1 interactions | BRIP1 MCM8 SPTBN2 EXOC3 CDKL5 ABHD16A PMS2 ANXA2 STAP2 MSH4 SNW1 ATM | 4.80e-06 | 244 | 195 | 12 | int:MLH1 |
| Interaction | LRRC7 interactions | 2.02e-05 | 58 | 195 | 6 | int:LRRC7 | |
| Interaction | RHOB interactions | FAM234A SPTBN1 SPTBN2 EXOC3 PCDH17 MICAL3 IMMT HSPA9 SLC12A6 ANXA2 DDX52 DOCK9 PKP4 RAB11FIP2 ADGRL1 ARHGAP35 FAM171B CIT SCYL2 SCARB1 MACF1 CDH2 | 2.25e-05 | 840 | 195 | 22 | int:RHOB |
| Interaction | RHOG interactions | PDE3B SPTBN1 SPTBN2 EXOC3 SUCLA2 PCDH17 DAP3 FAF2 SYNE2 IMMT HSPA9 SLC12A6 LAMTOR2 DOCK9 PKP4 ADGRL1 ARHGAP35 FAM171B CYFIP2 SCYL2 SCARB1 MACF1 CDH2 | 2.54e-05 | 910 | 195 | 23 | int:RHOG |
| Interaction | RAC2 interactions | FAM234A PDE3B SPTBN1 PCDH17 FAF2 SYNE2 IMMT LAMTOR2 DDX52 DOCK9 PKP4 ADGRL1 ARHGAP35 SHANK3 CYFIP2 SCARB1 MACF1 PLEKHA2 CDH2 | 3.14e-05 | 674 | 195 | 19 | int:RAC2 |
| Interaction | PTEN interactions | SPTBN1 BIRC6 LUZP1 FBXL5 DHX9 FSIP2 DAP3 SRGAP1 MME ASCC3 HSPA1L HSPA6 NPC1 USP22 ANXA2 CEP162 ANXA2P2 CIT SCYL2 LIG3 ATM USP39 EXOSC7 | 3.50e-05 | 929 | 195 | 23 | int:PTEN |
| Interaction | TRAF3IP1 interactions | 4.11e-05 | 96 | 195 | 7 | int:TRAF3IP1 | |
| Interaction | RHOJ interactions | SPTBN1 SPTBN2 EXOC3 TRIP10 PCDH17 MICAL3 IMMT HSPA6 DDX52 DOCK9 PKP4 ADGRL1 ARHGAP35 FAM171B SCYL2 SCARB1 MACF1 CDH2 | 4.58e-05 | 633 | 195 | 18 | int:RHOJ |
| Interaction | NEK4 interactions | ABCA13 NEB HELB DHX9 GREB1L NID1 HSPA1L IMMT HSPA6 HSPA9 AGTPBP1 CPNE9 CEP162 APOB ARHGAP35 MINDY2 CELSR3 | 5.39e-05 | 582 | 195 | 17 | int:NEK4 |
| Interaction | GJA1 interactions | ADGRG5 SPTBN1 EXOC3 FAF2 SYNE2 SEC16A FGA HSPA9 PKP4 APOB FAM171B CYFIP2 SCYL2 RGS14 MACF1 CDH2 PCDH9 | 5.51e-05 | 583 | 195 | 17 | int:GJA1 |
| Interaction | DNAJC7 interactions | DMXL1 BUB1B SEC16A WDR35 ASCC3 HSPA1L HSPA6 SLC12A6 ANXA2 SHANK3 CYFIP2 SNW1 ATM HERC4 | 7.13e-05 | 425 | 195 | 14 | int:DNAJC7 |
| Interaction | KCTD13 interactions | ATP6V1C1 SPTBN1 SPTBN2 SUCLA2 LUZP1 DHX9 CDKL5 TOMM70 SEC16A FGA MICAL3 HSPA1L IMMT HSPA9 AGTPBP1 SLC12A6 SORBS2 ANXA2 PKP4 ADGRL1 TPGS1 ARHGAP35 CIT SHANK3 CYFIP2 MAL2 PPP2R2C MACF1 CDH2 | 7.69e-05 | 1394 | 195 | 29 | int:KCTD13 |
| Cytoband | 18q11.2 | 5.18e-05 | 47 | 198 | 4 | 18q11.2 | |
| GeneFamily | Heat shock 70kDa proteins | 2.68e-04 | 17 | 137 | 3 | 583 | |
| GeneFamily | Rho GTPase activating proteins|F-BAR domain containing | 6.75e-04 | 23 | 137 | 3 | 1288 | |
| GeneFamily | Ubiquitin specific peptidases | 8.54e-04 | 56 | 137 | 4 | 366 | |
| GeneFamily | EF-hand domain containing|Spectrins | 1.17e-03 | 7 | 137 | 2 | 1113 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | MCM8 TTC39C IRAK2 DHX9 TOMM70 BUB1B MME ASCC3 HSPA9 ANXA2 DDX52 ANXA2P2 MIPOL1 SCYL2 CELSR3 WDHD1 SRGAP2B RIOK2 CDH2 HERC4 | 5.40e-07 | 721 | 196 | 20 | M10237 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_EARLY_AIRWAY_PROGENITOR_CELL | 1.18e-05 | 40 | 196 | 5 | M45691 | |
| Coexpression | GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP | LUZP1 MICAL3 ANXA2 TSEN54 ARHGAP35 PLEKHD1 CALHM2 MYO1F DUSP10 | 1.93e-05 | 198 | 196 | 9 | M6522 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000 | ATP6V1C1 ZNF148 SPTBN1 NEB BIRC6 MYSM1 DMXL1 GREB1L SYCP2 SYNE2 THG1L NID1 IMMT USP53 SLC12A6 TBC1D15 DOCK9 PKP4 MSH4 BCO1 | 2.74e-05 | 770 | 194 | 20 | gudmap_developingGonad_P2_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | ATP6V1C1 ZNF148 SPTBN1 NEB BIRC6 MYSM1 DMXL1 GREB1L SYCP2 SYNE2 IMMT USP53 SLC12A6 TBC1D15 SORBS2 DOCK9 PKP4 RAB11FIP2 MSH4 PCDH9 | 3.17e-05 | 778 | 194 | 20 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | RNF130 TTC39C NT5C3A ZNF813 HMGCS1 GREB1L MME FGFR2 NPC1 USP53 SLC12A6 SORBS2 ANXA2 DOCK9 RAB11FIP2 CYFIP2 SCYL2 MRO FEZ1 CDH2 | 5.02e-05 | 804 | 194 | 20 | gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_500 | ZNF148 SPTBN1 NEB BIRC6 MYSM1 DMXL1 GREB1L SYCP2 SYNE2 IMMT USP53 PKP4 MSH4 | 6.02e-05 | 387 | 194 | 13 | gudmap_developingGonad_e18.5_ovary_500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_500 | MYH8 ZNF148 SPTBN1 MYSM1 DMXL1 GREB1L SYCP2 SYNE2 IMMT USP53 SORBS2 PKP4 MSH4 | 6.02e-05 | 387 | 194 | 13 | gudmap_developingGonad_e16.5_ovary_500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | MYH8 ZNF148 SPTBN1 BIRC6 MYSM1 DMXL1 GREB1L SYCP2 SYNE2 THG1L IMMT USP53 TBC1D15 PMS2 GARNL3 PKP4 RAB11FIP2 MSH4 ATM | 9.59e-05 | 776 | 194 | 19 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | PDE3B MCM8 ATAD5 BIRC6 LUZP1 DHX9 MICAL3 ASCC3 DDX52 FHOD3 CIT CYFIP2 SNW1 ATM CDH2 | 1.18e-04 | 532 | 194 | 15 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | MYH8 ZNF148 SPTBN1 BIRC6 MYSM1 DMXL1 SYNE2 PKHD1 WDR35 NID1 IMMT USP53 SORBS2 PKP4 RAB11FIP2 FAM171B MAL2 FEZ1 PCDH9 | 1.36e-04 | 797 | 194 | 19 | gudmap_developingGonad_P2_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.40e-04 | 210 | 194 | 9 | gudmap_developingGonad_e18.5_ovary_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.77e-04 | 90 | 194 | 6 | gudmap_developingGonad_P2_epididymis_1000_k4 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-08 | 184 | 197 | 10 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-08 | 184 | 197 | 10 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-08 | 184 | 197 | 10 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-gd_T|COVID-19_Severe / Disease group, lineage and cell class | 2.28e-07 | 195 | 197 | 9 | 9990440bda7fac5d00ef80444fab07459be625e1 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.38e-07 | 196 | 197 | 9 | 418e8e0a51c5cb60e3b903e7d2d800dc8b9f3d5c | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.38e-07 | 196 | 197 | 9 | 581fc8c8d42005aacd7b401a2c9d1fc331fb4af7 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.38e-07 | 196 | 197 | 9 | 6beaf0c2799424c59819b286fbb5c1a83d85e4d1 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.38e-07 | 196 | 197 | 9 | c35f2349dfe35baa845f790b9f31673dceac54c0 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.82e-07 | 200 | 197 | 9 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | mild_COVID-19_(asymptomatic)-RBC|World / disease group, cell group and cell class (v2) | 8.95e-07 | 169 | 197 | 8 | 2bda6ab3f32e05cb7daf91eb7c39b4fcc9ae91bb | |
| ToppCell | mild_COVID-19_(asymptomatic)-RBC|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 9.78e-07 | 171 | 197 | 8 | 78491478ba65bad45238fe114f5251b2adea323d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.02e-06 | 172 | 197 | 8 | fb2df8fea6df5947165f13978f1d1006d15b60fd | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.02e-06 | 172 | 197 | 8 | 86f52f486d67217fc1b8443ab362c975df2974a4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.02e-06 | 172 | 197 | 8 | e38ebb216e4ddcd008148fcbaf709b4f3c83706a | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.27e-06 | 177 | 197 | 8 | d3e6c768b88b7906f3c7fdd00ba20842212c14b1 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.27e-06 | 177 | 197 | 8 | f8f101c772c043636bedd6b2ec81409b1d2599bf | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-NK_activated|COVID-19_Mild / Disease group, lineage and cell class | 1.27e-06 | 177 | 197 | 8 | 6978a22fef40c8b455342373abe7593f5ede0fa4 | |
| ToppCell | 3'_v3-blood-Hematopoietic_progenitors|blood / Manually curated celltypes from each tissue | 1.27e-06 | 177 | 197 | 8 | 22c77077951889e63489abfabf90900655655c82 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.27e-06 | 177 | 197 | 8 | 936ab2b180a052387124f68d0c7f41c0b164e748 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.27e-06 | 177 | 197 | 8 | d5aeda113afaa2425874394610344570c9078478 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-06 | 179 | 197 | 8 | d3438fed0d85d5ed5afa8ff820c45143d77b6c0d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-06 | 181 | 197 | 8 | aa233b652921848af2257cc3687a7a09c3acfb67 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-06 | 182 | 197 | 8 | f96095b81188b52db8fcfca4837129cfcd9bd7b7 | |
| ToppCell | COVID-19_Severe-gd_T|COVID-19_Severe / Disease condition and Cell class | 1.70e-06 | 184 | 197 | 8 | 791f1bcb954aadc63d4117c400537d036f68734d | |
| ToppCell | Control-T_cells|Control / group, cell type (main and fine annotations) | 1.91e-06 | 187 | 197 | 8 | f4e8e0eba58da89b56587667555a5d4754e108c7 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.99e-06 | 188 | 197 | 8 | f7dc29dfec68236883469e848be5db34f5526d6b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.99e-06 | 188 | 197 | 8 | 4154f4787483c7e076e87a187733a9f666742c3d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-06 | 189 | 197 | 8 | 8ff3c3232eff9de4b5c9b22ecb82bc509d773f58 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.15e-06 | 190 | 197 | 8 | 4836ea19308d2a96694f12ab0653b7ce7b101d2f | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-06 | 190 | 197 | 8 | c408d4033a130c0168159a5b6f286fd2b2a9a39d | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.15e-06 | 190 | 197 | 8 | e83fa8b711aa79a1767818474f1c193b674b1c31 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-06 | 190 | 197 | 8 | d4910c37045a8b8bb53b37625263bc0a47b6e3f8 | |
| ToppCell | COVID-19-kidney-CNT|kidney / Disease (COVID-19 only), tissue and cell type | 2.33e-06 | 192 | 197 | 8 | d32ae226d95b4b6adb99d14b602be09b661d4cd9 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-06 | 192 | 197 | 8 | ee27d27e3d269764dbe8711d0b37ff9331a298a9 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-06 | 193 | 197 | 8 | 536b277d90070c4571c592a3c6323b4bf4819f67 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-06 | 193 | 197 | 8 | 0499611c21d283321ef6dd24add154dea48da1b7 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.51e-06 | 194 | 197 | 8 | 8f4b63b0b9a40765205e4ca6bd94a675a83dbe3d | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 2.61e-06 | 195 | 197 | 8 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.71e-06 | 196 | 197 | 8 | 49cc0a2b9739abad61dff7292ea0b14d28ff35c4 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.71e-06 | 196 | 197 | 8 | 83aeb96a33802949238d8a097086a1812201d1b5 | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|lung / Disease (COVID-19 only), tissue and cell type | 2.71e-06 | 196 | 197 | 8 | 4ac4073380d939a73cec7413e9f3f5ef616d2924 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-06 | 198 | 197 | 8 | a7e5de81eb7d3d23812c179a001adbaab1506596 | |
| ToppCell | COVID-19_Severe-immature_Neutrophil|COVID-19_Severe / Disease condition and Cell class | 3.04e-06 | 199 | 197 | 8 | f82fa9d651e78f9ebbe6264e00a48c54b1786a69 | |
| ToppCell | COVID-19_Severe-immature_Neutrophil-|COVID-19_Severe / Disease condition and Cell class | 3.04e-06 | 199 | 197 | 8 | 42ea0c19c455bdb0ae89b428d09c333104c670dc | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.15e-06 | 200 | 197 | 8 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.15e-06 | 200 | 197 | 8 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.15e-06 | 200 | 197 | 8 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.15e-06 | 200 | 197 | 8 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.51e-06 | 143 | 197 | 7 | 7a7a9829ba63468c9745904d9e993590051207ab | |
| ToppCell | LA-15._Ventricular_Cardiomyocyte_III|LA / Chamber and Cluster_Paper | 4.21e-06 | 147 | 197 | 7 | 8970eb6b82589f39439c61a57d999661ec8342de | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.98e-06 | 165 | 197 | 7 | 9bd332e5ede759a00a47728ea5558c215efdd77a | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.72e-06 | 167 | 197 | 7 | 166b7b4ca0663cde6d88219ee0bcc1988d03dab8 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-D_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.05e-05 | 169 | 197 | 7 | 818ab7a6fd1940a22d3bd99fe15f0af888af6b3e | |
| ToppCell | 356C-Epithelial_cells-Epithelial-D_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.05e-05 | 169 | 197 | 7 | f982f2e0d341fa27229f443ebe5c0e4a9e63bda6 | |
| ToppCell | 3'_v3-blood-Hematopoietic_progenitors-HSC-MPP|blood / Manually curated celltypes from each tissue | 1.09e-05 | 170 | 197 | 7 | 1443d7fccc81088dd42dcbb9361e269872542274 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.09e-05 | 170 | 197 | 7 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-05 | 179 | 197 | 7 | a3922476f33d2e4137a12dbda21a1703dff79684 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-05 | 180 | 197 | 7 | 788d5fbf688365b5d92d3aa19b9f8e9448f8be5a | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.58e-05 | 180 | 197 | 7 | b294f9db1e2ff51c94cde64fae4c2b057c0030a1 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.64e-05 | 181 | 197 | 7 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 1.64e-05 | 181 | 197 | 7 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | PBMC-Control-cDC_12|Control / Compartment, Disease Groups and Clusters | 1.70e-05 | 182 | 197 | 7 | 4774066d0f9986abc3d13a2a3bc99ce4f1327ae0 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-05 | 182 | 197 | 7 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-05 | 182 | 197 | 7 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.76e-05 | 183 | 197 | 7 | b5ede5a0048c585b73c00e88aeddbcaf669347b1 | |
| ToppCell | COVID-19_Mild-gd_T|COVID-19_Mild / Disease condition and Cell class | 1.76e-05 | 183 | 197 | 7 | f593a89b0aa8fffdfa403769916facfd30358521 | |
| ToppCell | COVID-19_Mild-NK_activated|COVID-19_Mild / Disease condition and Cell class | 1.76e-05 | 183 | 197 | 7 | 22bd05135906d0ecc4ba8c2e0a666093d1bf3b8f | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-05 | 184 | 197 | 7 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | CV-Healthy-7|CV / Virus stimulation, Condition and Cluster | 1.82e-05 | 184 | 197 | 7 | 0e5cc77aaa73ceb791f8be7456177577fd2e5586 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.82e-05 | 184 | 197 | 7 | 226ccac00ac1c3a0ad7283785fd14312320e0ca6 | |
| ToppCell | COPD-Endothelial-VE_Venous|COPD / Disease state, Lineage and Cell class | 1.82e-05 | 184 | 197 | 7 | 44d716e7ba46a1ed03f5992631289653f8fd7d5e | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.82e-05 | 184 | 197 | 7 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.89e-05 | 185 | 197 | 7 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.95e-05 | 186 | 197 | 7 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-05 | 186 | 197 | 7 | 08632045d499e61dd96ff29a5a9a208afe58dc58 | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 1.95e-05 | 186 | 197 | 7 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-05 | 186 | 197 | 7 | b87acc80b7baa41681e4ed11d5537b9fbf5832f5 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Degenerative_Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-05 | 186 | 197 | 7 | b3358e0fa6d845c81e94d56c8575f016621d28ff | |
| ToppCell | Control-Endothelial-Endothelial-Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.02e-05 | 187 | 197 | 7 | ea9d34bcd3bd1f36745846309ede349773de501a | |
| ToppCell | COVID-19-Endothelial_cells-Pulmonary_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.02e-05 | 187 | 197 | 7 | 2d20193a6cacdfa4877457c97b0077408942186c | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-05 | 187 | 197 | 7 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | CV-Severe-3|Severe / Virus stimulation, Condition and Cluster | 2.02e-05 | 187 | 197 | 7 | 68cb43a73945f5e252530da25613f6b3f484b4d5 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-05 | 187 | 197 | 7 | f6217d0dd425eac76900b44a4e48f45475f3ac36 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-05 | 187 | 197 | 7 | 057569c9437219ecc396aa6e673b1178a2273837 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 187 | 197 | 7 | 14c239af77116d28d511dea754b6150d20488080 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 2.09e-05 | 188 | 197 | 7 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-05 | 188 | 197 | 7 | 315ce1736e3a84a63a8d5dfa70d411b501cb2532 | |
| ToppCell | droplet-Fat-SCAT-30m-Endothelial-Cd36+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-05 | 188 | 197 | 7 | e901a9bdf00b8e91806f445af66647373bf62661 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.09e-05 | 188 | 197 | 7 | 9abd78970bbe4ed03b59a83da63bbd334712f605 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.09e-05 | 188 | 197 | 7 | 5ae8ccdd328cf117da1d01ced2c3b7f763a5f1f1 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-05 | 189 | 197 | 7 | 90aae7e806882bebfad78a78e9a16cf56af3ecd4 | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.16e-05 | 189 | 197 | 7 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.24e-05 | 190 | 197 | 7 | d153a0bdedcd6865e6ee19575234a78b5d859ff1 | |
| ToppCell | facs-MAT-Fat-18m-Endothelial-endothelial_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-05 | 190 | 197 | 7 | 9aaa48f3aad813c87a45efdbb67d255c94f6e6a4 | |
| ToppCell | facs-MAT-Fat-18m-Endothelial|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-05 | 190 | 197 | 7 | 34e56c5e7ea6a8f227dbaefe73cbb8818d18b523 | |
| ToppCell | facs-MAT-Fat-18m-Endothelial-nan|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-05 | 190 | 197 | 7 | 14cdb660ad3aabcf49572173e7628d8b99dcbe6f | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-05 | 191 | 197 | 7 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.31e-05 | 191 | 197 | 7 | 1c1d13144259b998d4a0e85142f7afef2ef1e63f | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-05 | 191 | 197 | 7 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.31e-05 | 191 | 197 | 7 | 3c464645d0e7e423f791bd63bf5bcf11f6b590d3 | |
| Drug | Quercetine dihydrate [6151-25-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | PDE3B KIAA0586 EPS8L1 HMGCS1 NEB DMXL1 FBXL5 BUB1B CHPF2 TASOR WDHD1 HERC4 | 5.56e-08 | 180 | 196 | 12 | 2859_DN |
| Drug | Ketanserin tartrate hydrate [83846-83-7]; Down 200; 7uM; MCF7; HT_HG-U133A | BRIP1 LUZP1 DHX9 FGFR2 SLC12A6 SCYL2 FEM1B FEZ1 SCARB1 SUGP1 DUSP10 HERC4 | 1.20e-07 | 193 | 196 | 12 | 3209_DN |
| Drug | Dorzolamide hydrochloride [130693-82-2]; Down 200; 11uM; HL60; HT_HG-U133A | ATP6V1C1 GALNT2 DHX9 MINDY2 SCYL2 LIG3 SCARB1 SUGP1 PLEKHA2 ATM PSD4 | 8.71e-07 | 191 | 196 | 11 | 6142_DN |
| Drug | Nystatine [1400-61-9]; Down 200; 4.4uM; MCF7; HT_HG-U133A | BRIP1 ATAD5 NEB SUCLA2 FBXL5 FGFR2 TASOR DOCK9 SCYL2 ATM PSD4 | 1.37e-06 | 200 | 196 | 11 | 4807_DN |
| Drug | Fenbufen [36330-85-5]; Down 200; 15.8uM; MCF7; HT_HG-U133A | ATP6V1C1 PDE3B SYCP2 PMS2 RMND5A ADGRL1 ZNF34 SUGP1 ATM HERC4 | 6.77e-06 | 192 | 196 | 10 | 4743_DN |
| Drug | Cephalexin monohydrate [23325-78-2]; Down 200; 11uM; MCF7; HT_HG-U133A | BRIP1 SPTBN1 EPS8L1 FBXL5 FGFR2 DDX52 CEP162 SCYL2 MACF1 HERC4 | 8.12e-06 | 196 | 196 | 10 | 2628_DN |
| Drug | Bupropion hydrochloride [31677-93-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A | SPTBN1 ZNF813 FYCO1 EPS8L1 SYCP2 ADGRL1 CYFIP2 FEM1B ZNF430 SCARB1 | 8.87e-06 | 198 | 196 | 10 | 6256_DN |
| Drug | di-n-octyltin dichloride | 1.23e-05 | 6 | 196 | 3 | CID000077080 | |
| Drug | scriptaid; Up 200; 10uM; PC3; HT_HG-U133A | ATP6V1C1 HMGCS1 MGAT2 NPC1 SLC12A6 CYFIP2 DUSP10 HERC4 PCDH9 | 2.28e-05 | 176 | 196 | 9 | 6896_UP |
| Drug | Ketoconazole [65277-42-1]; Down 200; 7.6uM; HL60; HT_HG-U133A | 2.84e-05 | 181 | 196 | 9 | 1285_DN | |
| Drug | Tiletamine hydrochloride; Down 200; 15.4uM; MCF7; HT_HG-U133A | 4.51e-05 | 192 | 196 | 9 | 6013_DN | |
| Drug | Acetohexamide [968-81-0]; Down 200; 12.4uM; MCF7; HT_HG-U133A | PDE3B ATAD5 SYCP2 MICAL3 SLC12A6 RAB11FIP2 ADGRL1 ARHGAP35 SUGP1 | 4.88e-05 | 194 | 196 | 9 | 1707_DN |
| Drug | Metoprolol-(+,-) (+)-tartrate salt [56392-17-7]; Down 200; 5.8uM; MCF7; HT_HG-U133A | 5.29e-05 | 196 | 196 | 9 | 6846_DN | |
| Drug | Ranitidine hydrochloride [66357-59-3]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 5.29e-05 | 196 | 196 | 9 | 5425_DN | |
| Drug | PNU-0230031 [267429-39-0]; Up 200; 1uM; PC3; HT_HG-U133A | 5.29e-05 | 196 | 196 | 9 | 4291_UP | |
| Drug | Pyrilamine maleate [59-33-6]; Down 200; 10uM; MCF7; HT_HG-U133A | ATAD5 CEP162 RAB11FIP2 ADGRL1 FEM1B ZNF430 SUGP1 DUSP10 EXOSC7 | 5.50e-05 | 197 | 196 | 9 | 7223_DN |
| Drug | Myricetin [529-44-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A | CACNA2D2 EPS8L1 ZNF623 GREB1L SYCP2 ARHGAP35 MYO1F ATM PCDH9 | 5.50e-05 | 197 | 196 | 9 | 3270_DN |
| Drug | Panthenol (D) [81-13-0]; Up 200; 19.4uM; MCF7; HT_HG-U133A | 5.50e-05 | 197 | 196 | 9 | 1680_UP | |
| Drug | Tremorine dihydrochloride [300-68-5]; Up 200; 15uM; MCF7; HT_HG-U133A | 5.50e-05 | 197 | 196 | 9 | 3196_UP | |
| Drug | Drofenine hydrochloride [548-66-3]; Down 200; 11.4uM; MCF7; HT_HG-U133A | GALNT2 KIAA0586 SYCP2 CEP162 ARHGAP35 FEM1B LIG3 WDHD1 SUGP1 | 5.50e-05 | 197 | 196 | 9 | 3455_DN |
| Drug | Noscapine [128-62-1]; Down 200; 9.6uM; MCF7; HT_HG-U133A | KIAA0586 ZNF623 CEP162 FEM1B CELSR3 WDHD1 SCARB1 SUGP1 DUSP10 | 5.72e-05 | 198 | 196 | 9 | 7204_DN |
| Drug | Etoposide [33419-42-0]; Down 200; 6.8uM; PC3; HT_HG-U133A | 5.72e-05 | 198 | 196 | 9 | 6681_DN | |
| Drug | Sulfinpyrazone [57-96-5]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 5.72e-05 | 198 | 196 | 9 | 6230_UP | |
| Drug | 5186324; Down 200; 2uM; MCF7; HT_HG-U133A_EA | EPS8L1 SLC12A6 CEP162 RAB11FIP2 ARHGAP35 SCYL2 ZNF34 SUGP1 ELL | 5.95e-05 | 199 | 196 | 9 | 900_DN |
| Drug | Sertaconazole nitrate [99592-39-9]; Down 200; 8uM; PC3; HT_HG-U133A | DHX9 RMND5A CEP162 ARHGAP35 CYFIP2 SUGP1 PLEKHA2 HERC4 PCDH9 | 6.18e-05 | 200 | 196 | 9 | 4475_DN |
| Drug | (R)-(+)-Atenolol [56715-13-0]; Down 200; 15uM; MCF7; HT_HG-U133A | 6.18e-05 | 200 | 196 | 9 | 4841_DN | |
| Drug | norlorcainide | 7.37e-05 | 2 | 196 | 2 | CID000162188 | |
| Drug | carocainide | 7.37e-05 | 2 | 196 | 2 | CID000071970 | |
| Drug | 2,4,4-trimethyl-2-pentanol | 7.37e-05 | 2 | 196 | 2 | CID000094740 | |
| Drug | 3-phenylindole | 7.37e-05 | 2 | 196 | 2 | CID000096502 | |
| Disease | free cholesterol to total lipids in large VLDL percentage | 9.90e-05 | 37 | 193 | 4 | EFO_0022281 | |
| Disease | phosphatidylcholine measurement | 1.13e-04 | 284 | 193 | 9 | EFO_0010226 | |
| Disease | carotene diol (2) measurement | 1.27e-04 | 3 | 193 | 2 | EFO_0800171 | |
| Disease | carotene diol (1) measurement | 1.27e-04 | 3 | 193 | 2 | EFO_0800170 | |
| Disease | Vitelliform macular dystrophy | 1.27e-04 | 3 | 193 | 2 | cv:C0339510 | |
| Disease | Adult-onset foveomacular vitelliform dystrophy | 1.27e-04 | 3 | 193 | 2 | cv:C1842914 | |
| Disease | arthritis | 1.27e-04 | 3 | 193 | 2 | EFO_0005856 | |
| Disease | Synostotic Posterior Plagiocephaly | 1.45e-04 | 16 | 193 | 3 | C1833340 | |
| Disease | Craniosynostosis, Type 1 | 1.45e-04 | 16 | 193 | 3 | C4551902 | |
| Disease | Acrocephaly | 1.45e-04 | 16 | 193 | 3 | C0030044 | |
| Disease | Trigonocephaly | 1.45e-04 | 16 | 193 | 3 | C0265535 | |
| Disease | Scaphycephaly | 1.45e-04 | 16 | 193 | 3 | C0265534 | |
| Disease | Synostotic Anterior Plagiocephaly | 1.45e-04 | 16 | 193 | 3 | C2931150 | |
| Disease | Metopic synostosis | 1.45e-04 | 16 | 193 | 3 | C1860819 | |
| Disease | Brachycephaly | 1.75e-04 | 17 | 193 | 3 | C0221356 | |
| Disease | triglycerides in large LDL measurement | 1.79e-04 | 43 | 193 | 4 | EFO_0022319 | |
| Disease | spinocerebellar ataxia type 5 (implicated_via_orthology) | 2.53e-04 | 4 | 193 | 2 | DOID:0050882 (implicated_via_orthology) | |
| Disease | Vitelliform Macular Dystrophy | 2.53e-04 | 4 | 193 | 2 | C0339510 | |
| Disease | Juvenile-Onset Vitelliform Macular Dystrophy | 2.53e-04 | 4 | 193 | 2 | C2745945 | |
| Disease | Adult-Onset Vitelliform Macular Dystrophy | 2.53e-04 | 4 | 193 | 2 | C1842914 | |
| Disease | Craniosynostosis | 2.89e-04 | 20 | 193 | 3 | C0010278 | |
| Disease | aspartate aminotransferase measurement | BRIP1 GALNT2 CACNA2D2 FSTL4 FYCO1 BIRC6 KIF27 MYH7B ARHGAP35 MAL2 CROT FEZ1 ZNF827 SCARB1 SUGP1 ELL | 3.18e-04 | 904 | 193 | 16 | EFO_0004736 |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 3.63e-04 | 200 | 193 | 7 | EFO_0004611, EFO_0020945 | |
| Disease | Congenital absence of kidneys syndrome | 4.20e-04 | 5 | 193 | 2 | C1609433 | |
| Disease | vitelliform macular dystrophy (is_implicated_in) | 4.20e-04 | 5 | 193 | 2 | DOID:0050661 (is_implicated_in) | |
| Disease | Adenocarcinoma of lung (disorder) | 4.33e-04 | 206 | 193 | 7 | C0152013 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 4.42e-04 | 148 | 193 | 6 | C0279702 | |
| Disease | triglycerides in LDL measurement | 5.00e-04 | 56 | 193 | 4 | EFO_0022320 | |
| Disease | facial pigmentation measurement | 5.35e-04 | 57 | 193 | 4 | EFO_0006942 | |
| Disease | serine protease inhibitor Kazal-type 2 measurement | 6.27e-04 | 6 | 193 | 2 | EFO_0802054 | |
| Disease | lipoprotein measurement | 6.47e-04 | 105 | 193 | 5 | EFO_0004732 | |
| Disease | retinitis pigmentosa (implicated_via_orthology) | 7.18e-04 | 27 | 193 | 3 | DOID:10584 (implicated_via_orthology) | |
| Disease | red blood cell density measurement | TRIT1 FAM234A MLEC NT5C3A SPTBN1 EXOC3 PKHD1 TASOR PKP4 RAB11FIP2 MIPOL1 RGS14 ZNF827 HERC4 PSD4 | 7.19e-04 | 880 | 193 | 15 | EFO_0007978 |
| Disease | Colorectal Carcinoma | ABCA13 SPTBN2 CDKL5 ABCC8 BUB1B PKHD1 SCNN1B NID1 AGTPBP1 PMS2 APOB LIG3 DUSP21 | 7.69e-04 | 702 | 193 | 13 | C0009402 |
| Disease | Ciliopathies | 7.98e-04 | 110 | 193 | 5 | C4277690 | |
| Disease | urate measurement, bone density | PDE3B COL6A5 DNAH14 FREM1 PCDH17 FSIP2 SEC16A USH2A PLSCR4 RHCG DNAH1 SCYL2 | 8.26e-04 | 619 | 193 | 12 | EFO_0003923, EFO_0004531 |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 1.14e-03 | 243 | 193 | 7 | EFO_0004612, EFO_0020944 | |
| Disease | pneumococcal meningitis | 1.16e-03 | 8 | 193 | 2 | EFO_1001114 | |
| Disease | Unilateral agenesis of kidney | 1.16e-03 | 8 | 193 | 2 | C0266294 | |
| Disease | Spinocerebellar Ataxia Type 2 | 1.42e-03 | 34 | 193 | 3 | C0752121 | |
| Disease | Spinocerebellar Ataxia Type 1 | 1.42e-03 | 34 | 193 | 3 | C0752120 | |
| Disease | Spinocerebellar Ataxia Type 5 | 1.42e-03 | 34 | 193 | 3 | C0752123 | |
| Disease | Spinocerebellar Ataxia Type 7 | 1.42e-03 | 34 | 193 | 3 | C0752125 | |
| Disease | Spinocerebellar Ataxia Type 6 (disorder) | 1.42e-03 | 34 | 193 | 3 | C0752124 | |
| Disease | Ataxia, Spinocerebellar | 1.42e-03 | 34 | 193 | 3 | C0087012 | |
| Disease | glioblastoma (implicated_via_orthology) | 1.49e-03 | 9 | 193 | 2 | DOID:3068 (implicated_via_orthology) | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 1.52e-03 | 127 | 193 | 5 | EFO_0008595, EFO_0020947 | |
| Disease | Spinocerebellar Ataxia Type 4 | 1.55e-03 | 35 | 193 | 3 | C0752122 | |
| Disease | triacylglycerol 52:4 measurement | 1.68e-03 | 36 | 193 | 3 | EFO_0010416 | |
| Disease | Developmental delay (disorder) | 1.82e-03 | 37 | 193 | 3 | C0424605 | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 1.85e-03 | 10 | 193 | 2 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 1.85e-03 | 10 | 193 | 2 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 1.85e-03 | 10 | 193 | 2 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 1.85e-03 | 10 | 193 | 2 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 1.85e-03 | 10 | 193 | 2 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 1.85e-03 | 10 | 193 | 2 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 1.85e-03 | 10 | 193 | 2 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 1.85e-03 | 10 | 193 | 2 | DOID:0080326 (implicated_via_orthology) | |
| Disease | hepatocyte growth factor-like protein measurement | 1.96e-03 | 38 | 193 | 3 | EFO_0008154 | |
| Disease | coagulation factor XA measurement | 2.25e-03 | 11 | 193 | 2 | EFO_0020266 | |
| Disease | thrombin generation potential measurement | 2.25e-03 | 11 | 193 | 2 | EFO_0005538 | |
| Disease | Profound Mental Retardation | 2.25e-03 | 139 | 193 | 5 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 2.25e-03 | 139 | 193 | 5 | C0025363 | |
| Disease | Mental deficiency | 2.25e-03 | 139 | 193 | 5 | C0917816 | |
| Disease | retinal vasculature measurement | SPTBN1 LUZP1 FGFR2 PMS2 SORBS2 RAB11FIP2 MUC12 COG8 FEZ1 XIRP2 | 2.26e-03 | 517 | 193 | 10 | EFO_0010554 |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 2.36e-03 | 276 | 193 | 7 | EFO_0004612, EFO_0020943 | |
| Disease | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | 2.43e-03 | 206 | 193 | 6 | EFO_0004612, EFO_0020947 | |
| Disease | Glioma | 2.59e-03 | 87 | 193 | 4 | C0017638 | |
| Disease | distal myopathy (implicated_via_orthology) | 2.69e-03 | 12 | 193 | 2 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 2.69e-03 | 12 | 193 | 2 | DOID:2106 (implicated_via_orthology) | |
| Disease | total blood protein measurement | 2.93e-03 | 449 | 193 | 9 | EFO_0004536 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 3.16e-03 | 291 | 193 | 7 | EFO_0008317, EFO_0020946 | |
| Disease | squamous cell carcinoma, multiple keratinocyte carcinoma susceptibility measurement, basal cell carcinoma | 3.17e-03 | 13 | 193 | 2 | EFO_0000707, EFO_0004193, EFO_0007932 | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 3.17e-03 | 13 | 193 | 2 | DOID:397 (implicated_via_orthology) | |
| Disease | coagulation factor X measurement | 3.17e-03 | 13 | 193 | 2 | EFO_0020265 | |
| Disease | Short Rib-Polydactyly Syndrome | 3.17e-03 | 13 | 193 | 2 | C0036996 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 3.51e-03 | 222 | 193 | 6 | EFO_0008317, EFO_0020943 | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 3.67e-03 | 224 | 193 | 6 | EFO_0004530, EFO_0008317 | |
| Disease | Saldino-Noonan Syndrome | 3.68e-03 | 14 | 193 | 2 | C0036069 | |
| Disease | Majewski Syndrome | 3.68e-03 | 14 | 193 | 2 | C0024507 | |
| Disease | renal cell carcinoma (biomarker_via_orthology) | 3.68e-03 | 14 | 193 | 2 | DOID:4450 (biomarker_via_orthology) | |
| Disease | forehead morphology measurement | 4.23e-03 | 15 | 193 | 2 | EFO_0007844 | |
| Disease | low density lipoprotein triglyceride measurement | 4.23e-03 | 15 | 193 | 2 | EFO_0009946 | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 4.23e-03 | 15 | 193 | 2 | DOID:0050646 (implicated_via_orthology) | |
| Disease | triacylglycerol 52:3 measurement | 4.23e-03 | 15 | 193 | 2 | EFO_0010415 | |
| Disease | response to statin, LDL cholesterol change measurement | 4.23e-03 | 15 | 193 | 2 | EFO_0007804, GO_0036273 | |
| Disease | Rhabdomyosarcoma | 4.23e-03 | 15 | 193 | 2 | C0035412 | |
| Disease | cholesteryl esters to total lipids in IDL percentage | 4.31e-03 | 50 | 193 | 3 | EFO_0022247 | |
| Disease | Weight Gain | 4.58e-03 | 102 | 193 | 4 | C0043094 | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 4.74e-03 | 103 | 193 | 4 | EFO_0008595, EFO_0020944 | |
| Disease | Tremor, Rubral | 4.81e-03 | 16 | 193 | 2 | C0750940 | |
| Disease | Ataxia, Appendicular | 4.81e-03 | 16 | 193 | 2 | C0750937 | |
| Disease | Ataxia, Motor | 4.81e-03 | 16 | 193 | 2 | C0278161 | |
| Disease | neutrophil collagenase measurement | 4.81e-03 | 16 | 193 | 2 | EFO_0008248 | |
| Disease | Ataxia, Sensory | 4.81e-03 | 16 | 193 | 2 | C0240991 | |
| Disease | Abnormal coordination | 4.81e-03 | 16 | 193 | 2 | C0520966 | |
| Disease | Ataxia, Truncal | 4.81e-03 | 16 | 193 | 2 | C0427190 | |
| Disease | Retinitis Pigmentosa | 4.90e-03 | 104 | 193 | 4 | C0035334 | |
| Disease | serum alanine aminotransferase measurement | BRIP1 HSPA6 NPC1 MYH7B STAP2 APOB CYFIP2 CROT FEZ1 ZNF827 SUGP1 RP1 ELL | 4.91e-03 | 869 | 193 | 13 | EFO_0004735 |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 5.02e-03 | 239 | 193 | 6 | EFO_0008317, EFO_0020945 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HQQLYYSQDDSNRKN | 1111 | Q99569 | |
| ALRNTEYFNQLKDNS | 256 | Q9H0P0 | |
| CNNTLQQQKRAFEYE | 51 | O60566 | |
| QKRNNVYFSQSAANL | 1751 | Q96QE3 | |
| QDVLFLYKNTNSSNN | 106 | Q9H0X4 | |
| ATFQQLDQEYKINSR | 161 | Q9Y2R4 | |
| ATNNLYIFQDKVNSD | 431 | Q9Y2T4 | |
| IQANQYNSRATAFIK | 161 | P41595 | |
| ISSSEQRQSYKNDFN | 516 | P55199 | |
| NDFNIKENKSVRNYQ | 146 | Q5JVX7 | |
| NKENGADIFLYNANR | 2676 | Q9NR09 | |
| TEKNYNSFVLQNLNR | 6 | Q13939 | |
| EYAFDQLQNSNITRA | 376 | Q9NY47 | |
| GNRVDYAFNTNANRE | 341 | O94910 | |
| QVRASAIAQDADQNY | 196 | Q5VWW1 | |
| IASAFRNEEYNKSVQ | 46 | P19652 | |
| ENKRQLANYNFDFRS | 141 | O95870 | |
| NDFLSNNLTNYGEKF | 1306 | Q86UQ4 | |
| TNRSNAQRQDIAFAY | 61 | P07355 | |
| TNRDNAQRQDIVFSY | 61 | A6NMY6 | |
| AYRFNIINCEKSNSQ | 761 | Q9UPW5 | |
| NQLSKESYDELFQTQ | 1436 | Q9Y485 | |
| AELNNQNFYLSKQLD | 961 | O14578 | |
| ELYNQFAANSERSQT | 101 | Q8N4T4 | |
| NDFLNDQNRDKNSIY | 281 | Q01581 | |
| ANQAENADYRTNLFV | 961 | O14917 | |
| RADNASQEYYTALIN | 26 | Q86XS8 | |
| TYRTRQNFKGFDDNN | 101 | Q9NW15 | |
| EDFVSENSNNKRAPY | 141 | P21802 | |
| RRYNQKNVSENSQDY | 261 | Q9H3H1 | |
| QKSQAFLYNNNRQTE | 736 | O00370 | |
| LSYAREAADFSTQQQ | 336 | Q7RTP6 | |
| SALNNVAERTYNNIF | 781 | Q9UJA3 | |
| YQLNFDQTLRNVDKA | 96 | Q10469 | |
| NQNRKISQGTFADVY | 211 | O43187 | |
| QEENLKDQFNYTLST | 351 | Q8TD10 | |
| FNKSSLEYRALEQQF | 591 | Q17R60 | |
| YFAQSQQKVFDVRLN | 131 | Q14165 | |
| ALQADYQALQQRESA | 641 | Q9BQS8 | |
| QDPYARNKFNQVESD | 96 | Q10471 | |
| TDSNKQNLRQYFEEA | 376 | Q9Y6W6 | |
| VENNANISIANKYDN | 141 | Q9UK73 | |
| YSRNQKSAYADDNQI | 2216 | Q5CZC0 | |
| AQYRANEDQLFQRTA | 221 | Q9HA72 | |
| DESLNSLKYANRARN | 326 | Q86VH2 | |
| SYKRQFEEAEQQANT | 1926 | A7E2Y1 | |
| YKRQAEEAEEQSNAN | 1881 | P13535 | |
| CFETNNRYDIKNNSD | 136 | Q9NRQ2 | |
| DSNRNQFNDRKQYGS | 1186 | Q9HC56 | |
| FLAEFNAKANDVNSN | 901 | Q13370 | |
| KSNGAYNIFANDRES | 231 | P14543 | |
| TAVNKQNRQEFVDAY | 886 | Q5GLZ8 | |
| NFTQQDVDSKNVAYR | 1566 | Q5H8C1 | |
| FISQFKRLTDAQNNY | 1021 | Q96J66 | |
| EYFENIIQNLKFSQS | 506 | P08473 | |
| LQQTRDLAFANYKTF | 76 | Q96MW5 | |
| ALLAQTKFGDYNQNT | 121 | Q8WY64 | |
| QVDNFTLDINTAYAR | 531 | Q16891 | |
| YFNDSQRQATKDAGV | 151 | P34931 | |
| FQSEEDQRNTKLYQQ | 216 | Q9BYG7 | |
| NVCFRNYNAKTENLA | 71 | Q99689 | |
| KARDLDVGSNNVQNY | 156 | Q9Y5E8 | |
| SVAQVFLNNYDAENK | 101 | P24158 | |
| FNQAIRNTIYAALQD | 471 | Q96F07 | |
| NAYEAFKASRNLQDV | 436 | P49916 | |
| ANTLYRIFNNKSSVD | 106 | Q15024 | |
| YFNDSQRQATKDAGQ | 196 | P38646 | |
| LNTDLTQNVQYDFNR | 1696 | Q9C091 | |
| QFQEENQSLTSDYKR | 361 | Q96MC2 | |
| NNSNISAKRNYFSEL | 711 | Q9UPN3 | |
| QRSQQYEQAADAELA | 5671 | Q9UPN3 | |
| NSRFADDYKIAIQQT | 541 | Q9BX63 | |
| DDQNYNNATALVITF | 551 | O15118 | |
| ELNNNDIASFLKTYQ | 756 | Q9P2D7 | |
| QQTAFENAYLKAQEG | 1116 | Q13315 | |
| FDQSRYRFVNNNLSQ | 211 | Q9UKF2 | |
| FSKQNALLRSEYQAD | 1591 | P04114 | |
| NRNNALDFVTKSYNE | 3211 | P04114 | |
| EKNFARFTYVTELNN | 331 | Q8NA47 | |
| DKNARFSAIYRQDSN | 541 | Q9BZ29 | |
| FSAIYRQDSNKLSND | 546 | Q9BZ29 | |
| ATREQNQKNAAYNLG | 376 | Q6ZN84 | |
| AYQNLRQKVDNFVST | 81 | Q96IK1 | |
| TKEEFQLNRYFTQQE | 676 | A8TX70 | |
| DLAFQRSFTESNQYN | 736 | Q6MZW2 | |
| QNLRFDVYNVDSKTN | 81 | Q8IYJ1 | |
| NENSIDYISRFNDLA | 1226 | Q96RY5 | |
| NQVRDLREKYSNFGN | 391 | Q2V2M9 | |
| SDAQDNADYRLFQKT | 231 | Q9NSG2 | |
| EKRKFNQNSNSTYCV | 171 | Q13639 | |
| NQDNYILQAKLSSFE | 666 | Q5TB80 | |
| ELARKQLSQQDHYNF | 1296 | Q0VDD8 | |
| LSDNQYNINVAASIF | 141 | Q969L2 | |
| EFALNNENYSLSNRQ | 406 | Q86V48 | |
| DFSSANNRDNTYNRV | 116 | P02671 | |
| AGSYKAQINQRNFEV | 126 | Q9HBG7 | |
| YDRNGNQAFNEDNLK | 56 | Q9Y2Q5 | |
| IASAFRNEEYNKSVQ | 46 | P02763 | |
| NNNDFRALLQSLYAT | 36 | Q9UKA1 | |
| YFNDSQRQATKDAGA | 151 | P17066 | |
| FQKNQTNLERKFSYD | 141 | Q8NBJ4 | |
| NFQILFNNYVSNRSD | 1171 | Q9NYQ7 | |
| NYDFQARNSSELSVK | 486 | Q8TE68 | |
| LSANDYFSERIKNQF | 111 | Q6SJ93 | |
| QQMNSFLSRYKDEAQ | 456 | O60645 | |
| FARNLSEGNNANYTE | 156 | O76039 | |
| KARNAYLNNSNYEEG | 111 | Q9UHW9 | |
| EFNYRTIEESAANNI | 501 | P51168 | |
| RESPNVKNNIYNATF | 561 | P19022 | |
| VKNNIYNATFLASDN | 566 | P19022 | |
| LRSDLDNGNNSFQYK | 66 | Q9H159 | |
| EQLINYEFKLFNNNT | 151 | Q9H596 | |
| KIYNEDVSFLSVNQN | 461 | Q6P995 | |
| VSNYKNLNFENLRET | 151 | Q8NG08 | |
| NQQNDNYRLKIFSEE | 336 | Q5VVW2 | |
| DAQSNAARDFVNYLV | 56 | Q08211 | |
| NQAKAQYLREASDLQ | 381 | Q9UKG9 | |
| ENSGRSKNFSYNLQS | 1041 | Q9Y283 | |
| ENCSLRKFQDENAYT | 1421 | P56715 | |
| DLNDNTSQAYRDFNK | 951 | Q9H195 | |
| RASQYYQEQEQAAAA | 556 | Q8NBR6 | |
| RDLLQSSYNKQRFDQ | 166 | P51398 | |
| RNIYQLSFRQNASDK | 361 | Q9GZV3 | |
| ALSQRYFLQANDQKD | 86 | Q9HB19 | |
| EQNFTDKNLEPNSRY | 3731 | O75445 | |
| QIDNDLKSRASAYNN | 131 | P21283 | |
| YNSNRDFQHVEKLNL | 51 | Q9UGK3 | |
| GTTNQREALQYAKNF | 206 | Q9H871 | |
| AKRRANQQETEQFYF | 426 | Q7Z6B7 | |
| DVYQADAVATFRKNN | 451 | Q7Z6J9 | |
| KANDYANAVLQALSN | 231 | Q53GS9 | |
| ENLKQILNNYSAQFS | 4006 | Q8WXH0 | |
| RAFKESQRQTDSKNY | 1161 | Q8IVG5 | |
| AKIEQYFDKAQNTNS | 1491 | Q8IVG5 | |
| SESKQRNLNYFSNAY | 96 | Q6P1X5 | |
| QQQDEAYLASLRADQ | 291 | Q96CS3 | |
| VAAYLQKNNDFSRAV | 606 | Q8NDX1 | |
| LFRASDSNANQKEFN | 1366 | Q5VXU9 | |
| KQAENFAYRLELNGN | 256 | O43255 | |
| YQNSFQNKKRNTTEE | 11 | A0A1B0GTD5 | |
| QYFDTLFQRDNLQKS | 336 | Q6P3W7 | |
| NNNDTVSFLEYRTFQ | 106 | Q8WTV0 | |
| QSLNLEQYAAEFAAR | 336 | Q8IZD0 | |
| AKRRANQQETEQFYF | 436 | P0DMP2 | |
| GNKRAYAENTVASNF | 86 | O15457 | |
| LLQNNADDFTSRYLN | 816 | P08F94 | |
| ISNFRDYIAETLQQN | 351 | Q9BZV3 | |
| NRNFDDQLKFVSNLY | 171 | Q9NRY4 | |
| NFDSNSAYRQKKIFD | 276 | Q9P2R7 | |
| KYNFNADTNVELSLR | 946 | O94875 | |
| RDTKQAEAFLNNQEY | 1176 | Q01082 | |
| RSNSFNTDRNIDKYN | 341 | Q9UK61 | |
| RFQQKLLEYTDSNNI | 1221 | Q09428 | |
| YLANLNQDFKENSRL | 336 | Q9HAY6 | |
| FFKDENNSSLLNNYV | 141 | Q8IZF4 | |
| RSFSNVTKQDNYNEE | 11 | Q8N3C0 | |
| SKNEYAAQLQRFNRD | 186 | Q15642 | |
| EQDFIIQNLKRNSSY | 126 | Q8WTT0 | |
| QGQQYRSFELAKNRD | 276 | Q9P2E5 | |
| YNKNERNDLSTSFEN | 381 | Q86WS4 | |
| FYRVTDENAKNSELN | 276 | Q70EK8 | |
| LQNNRENQAFSFLYE | 286 | Q8IWZ8 | |
| SADVQQARYVFENTN | 361 | A4UGR9 | |
| QARYVFENTNDSSQK | 366 | A4UGR9 | |
| ESENFDKNNYIRTVS | 1251 | A4UGR9 | |
| NLYSQLNALQFTVDE | 521 | A0JNW5 | |
| NSDLLNSNRSYAGKQ | 116 | Q6P2D0 | |
| DFNQSLSLIKQNNSY | 521 | Q8IYN0 | |
| NSGNNENKYSLFAVV | 356 | A6NNY8 | |
| SLNNDNKYSLFAVVN | 456 | Q9UPT9 | |
| NLDRFYQQVTKDAQG | 1036 | O15027 | |
| QRLAQAASLYQFQAD | 741 | O15020 | |
| GANRDVRNYNSQTAF | 306 | Q9BYB0 | |
| SIAVAKAFASQNNYR | 321 | Q86WA9 | |
| KAFASQNNYRIDANQ | 326 | Q86WA9 | |
| EEREFYSSQSQALQN | 321 | A6NEE1 | |
| QEAYKQQNATENRFS | 71 | P0DTU3 | |
| KNEILFSEFNINYNN | 216 | Q9NWX6 | |
| KQASAASYFQKRNSQ | 971 | O75717 | |
| ENYFTSQRDNIFRNV | 71 | Q7L523 | |
| IFQKFSAYQKSEQQR | 1446 | Q9BX26 | |
| TEKNVDLSTFYQNRA | 146 | O94826 | |
| DLSTFYQNRAAAFEQ | 151 | O94826 | |
| FFLNSIYKSRDEANN | 2221 | P08922 | |
| ATEKFDLSNLQNNYA | 281 | Q9BWV7 | |
| QEARNIYQEFLSSQA | 116 | O43566 | |
| LKSPNAFSENRQDYF | 386 | Q7L804 | |
| TSNEVQYDQRLFNQS | 401 | Q13573 | |
| NRTDRTNKFYEGQDN | 416 | Q8TC07 | |
| FSEEKNRTENYNRQD | 416 | Q9BVS4 | |
| NYGNNFRNSSLLTQK | 191 | Q6ZN06 | |
| AQQSEGEQNYRKFRA | 636 | P54278 | |
| QSKERQNSVYQSDLF | 206 | Q9UBD6 | |
| KQEQNDQYTPSNRFI | 176 | Q17R98 | |
| YGKAFNQSSNLIEQS | 546 | Q9H8G1 | |
| QEAYKQQNATENRFS | 71 | A0JD32 | |
| YLQAASNNSREYALN | 476 | Q9UQR1 | |
| LNNGFRESDQLFKQY | 41 | Q8N584 | |
| QYGRDFNSTTNVKNN | 491 | O75123 | |
| NRQRKDSFQENEDGY | 126 | Q5VYS8 | |
| QANNAIGDYFADRQK | 801 | Q9P2L0 | |
| NLYINNELQDFTKTQ | 1316 | O75093 | |
| SQRAAFNNNVSVAYE | 111 | Q6ZTW0 | |
| SRTDYEQKRFDQKNQ | 541 | Q9BVV6 | |
| AEDFSQYQLKQNQDV | 1421 | Q9BVV6 | |
| EQSFEQRSYLNNHKR | 201 | Q8IZ26 | |
| QEAYKQQNATENRFS | 71 | A0A0B4J264 | |
| TNYAINKHNENFVRD | 291 | A6NNM8 | |
| TARYFAKFAPDNEQN | 71 | Q6P5S2 | |
| SSQEYQNFSTLFKNR | 5191 | Q9UKN1 | |
| DYSETLRSFLQAAQQ | 591 | Q9UQQ1 | |
| RNNNSSRFGKYFEIQ | 161 | O00160 | |
| IENLFLSNYKSNQEN | 801 | Q5VVJ2 | |
| KRNQENFSSVLYKEN | 6236 | P20929 |